Correspondence | Published:

Response to Dr. Baldassarre

The American Journal of Gastroenterology (2018) | Download Citation

Subjects

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Baldassarre M. Probiotic genera/species identification is insufficient for evidence-based medicine. Am J Gastroenterol. 2018 https://doi.org/10.1038/s41395-018-0236-z.

  2. 2.

    Koretz RL. Probiotics in gastroenterology: How pro is the evidence in adults? Am J Gastroenterol. 2018;113:1125–1136 https://doi.org/10.1038/s41395-018-0138-0.

  3. 3.

    Biagioli M, Laghi L, Carino A, et al. Metabolic variability of amultispecies probiotic preparation impacts on the anti-inflammatory activity. Front Pharmacol. 2017;8:505 https://doi.org/10.3389/fphar.2017.00505.

  4. 4.

    Trinchieri V, Laghi L, Vitali B, et al. Efficacy and safety of a multistrain probiotic formulation depends from manufacturing. Front Immunol. 2017;8:1474 https://doi.org/10.3389/fimmu.2017.01474.

  5. 5.

    Hoffmann DF, Fraser CM, Palumbo F, et al. Federal regulation of probiotics: an analysis of the existing regulatory framework and recommendations for alternative frameworks. http://www.law.umaryland.edu/programs/health/events/probiotics/documents/FinalWhitePaper.pdf.

Download references

Author information

Affiliations

  1. Department of Medicine, Division of Gastroenterology, Olive View-UCLA Medical Center, Sylmar, California, USA

    • Ronald L. Koretz MD
  2. Emeritus Professor of Clinical Medicine, David Geffen-UCLA School of Medicine, Los Angeles, California, USA

    • Ronald L. Koretz MD

Authors

  1. Search for Ronald L. Koretz MD in:

Guarantor of the article

Ronald L. Koretz, MD.

Specific author contributions

Dr. Koretz wrote this letter.

Funding support

None.

Potential competing interests

Dr. Koretz does receive assistance from GIIssues, Inc., a non-profit 501 (c) (3) organization that was created to promote the use of evidence-based medicine. This assistance is only for academic activities (e.g., travel to meetings, research funding, subscriptions to medical journals, and professional organization dues and fees). Dr. Koretz does not receive any salary or other personal money from GIIssues, Inc.

Corresponding author

Correspondence to Ronald L. Koretz MD.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/s41395-018-0249-7